CDK3 Inhibitors therapy(senex biotechnology)

N/A

Report date: 2024/11/07 17:35:06
NME

Base Information

Drug NameCDK3 Inhibitors therapy(senex biotechnology)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin Dependent Kinase 3 inhibitors
TargetsCyclin Dependent Kinase 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSenex Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesSenex Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A